Market Place
Sourcing Support
All News #Library
Others
Cellworks Study Predicts Immune Checkpoint Inhibitor Resistance
29 Apr 2025 //
BUSINESSWIRE
Cellworks Enhances TRI for NSCLC Immunotherapy Survival Prediction
12 Nov 2024 //
BUSINESSWIRE
Cellworks Biosimulation Enhances IO Response Predictions In NSCLC
16 Sep 2024 //
BUSINESSWIRE
Cellworks Biosimulation Predicts PARPi Benefit In Multiple Cancers
16 Sep 2024 //
BUSINESSWIRE
Cellworks: Dr. Donovan Joins For Personalized Cancer Therapy Simulation
28 May 2024 //
BUSINESSWIRE
Cellworks Personalized Therapy Biosimulation Study Produces Superior OS
11 Mar 2024 //
BUSINESSWIRE
Cellworks Expands Into Precision to Accelerate the Development of Cancer Drugs
09 Jan 2023 //
BUSINESSWIRE
Cellworks Study Reveal Biomarkers That Predict Response to Hypomethylating Agent
12 Dec 2022 //
BUSINESSWIRE
Cellworks Biosimulation Study Reveals Promising Biomarkers for TMZ Resistance
22 Nov 2022 //
BUSINESSWIRE
Cellworks Singula TRI Provides Superior OS Predictions for NSCLC Patients
09 Aug 2022 //
BUSINESSWIRE
myCare-023 Finds Cellworks Biosimulation a Strong Predictor of Therapy Response
14 Dec 2021 //
BUSINESSWIRE
4baseCare with Cellworks to bring AI-driven personalised cancer care
27 Oct 2021 //
PHARMABIZ
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.